The Effects of Repetitive Use and Pathological Remodeling on Channelrhodopsin Function in Cardiomyocytes

Balázs Ördög1, Alexander Teplenin1, Tim De Coster1

  • 1Laboratory of Experimental Cardiology, Department of Cardiology, Leiden University Medical Center, Leiden, Netherlands.

Frontiers in Physiology
|September 20, 2021
PubMed

Insights

Channelrhodopsin (ChR) variants function similarly in healthy and hypertrophic heart cells but exhibit distinct use-dependent properties. This variant-specific behavior is crucial for designing cardiac optogenetics studies.

Area of Science:

  • Optogenetics
  • Cardiology
  • Molecular Biology

Background:

  • Channelrhodopsins (ChRs) are light-gated ion channels vital for optogenetics.
  • Selecting appropriate ChR variants is critical for specific applications, yet data for cardiac optogenetics is limited.
  • Understanding ChR behavior in both healthy and diseased cardiac conditions is essential.

Purpose of the Study:

  • To investigate the functional properties of different ChR variants in cardiomyocytes.
  • To assess ChR performance in both normal and pathological hypertrophic cardiac models.
  • To evaluate the impact of various illumination protocols on ChR function.

Main Methods:

  • Neonatal rat ventricular cardiomyocytes (NRVMs) were transduced to express ChR variants (H134R, CatCh, ReaChR, GtACR1).
  • Cardiac hypertrophy was induced using phenylephrine (PE) treatment.
  • ChR currents and membrane potential (Vm) responses were analyzed under single and repetitive light pulse stimulations.

Main Results:

  • Each ChR variant exhibited unique current and Vm responses upon activation.
  • GtACR1 showed a distinct Vm plateau compared to other variants.
  • Peak and plateau currents decreased with increasing activation frequencies in a variant-specific manner, while Vm remained stable; no significant differences were observed between healthy and hypertrophic cells.

Conclusions:

  • ChR variants perform comparably in healthy and hypertrophic cardiomyocyte models.
  • A significant variant-specific use-dependence was observed in ChR function.
  • These findings highlight the importance of considering ChR variant properties for cardiac optogenetic applications.

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
105
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.0K
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
96
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
117
Channel Rhodopsins01:11

Channel Rhodopsins

Most organisms use photoreceptors to sense and respond to light. Examples of photoreceptors include bacteriorhodopsins and bacteriophytochromes in some bacteria, phytochromes in plants, and rhodopsins in the photoreceptor cells of the vertebral retina. The light-sensitive property of these receptors is because of the bound chromophores, such as bilin in the phytochromes and retinal in the rhodopsins.
Rhodopsins belong to the family of cell surface proteins called G-protein coupled receptors,...
2.8K
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
77